Article information
Full text is only aviable in PDF
REFERENCES
[1]
S Greenfield, EC Nelson, M Zubkoff, W Manning, W Rogers, RL Kravitz, et al.
Variations in resource utilization among medical specialities and systems of care. Results from the medical outcomes study.
JAMA, 267 (1992), pp. 1624-1630
[2]
SE Reis, R Holubkov, D Edmundowicz, DM McNamara, KA Zell, K Detre, et al.
Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes.
J Am Coll Cardiol, 30 (1997), pp. 733-738
[3]
P Jong, Y Gong, PP Liu, PC Austin, DS Lee, JV Tu.
Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists.
Circulation, 108 (2003), pp. 129-131
[4]
CE Bucknall, C Robertson, F Moran, RD Stevenson.
Differences in hospital asthma management.
Lancet, 1 (1988), pp. 748-750
[5]
PH Mayo, J Richman, HW Harris.
Results of a program to reduce admissions for adult asthma.
Ann Intern Med, 112 (1990), pp. 864-871
[6]
RS Zeiger, S Heller, MH Mellon, J Wald, R Falkhoff, M Schatz.
Facilitated referral to asthma specialist reduces relapses in asthma emergency room visits.
J Allergy Clin Immunol, 87 (1991), pp. 1160-1168
[8]
DM Hughes, M McLeod, B Garner, RB Goldbloom.
Controlled trials of a home and ambulatory program for asthmatic children.
Pediatrics, 87 (1991), pp. 54-61
[9]
MJ Strauss, D Conrad, JP LoGerfo, LD Hudson, M Bergner.
Cost and outcome of care for patients with chronic obstructive lung disease. Analysis by physician specialty.
Med Care, 24 (1986), pp. 915-924
[10]
CR Regueiro, MB Hamel, RB Davis, N Desbiens, AF Connors Jr, RS Phillips.
A comparison of generalist and pulmonologist care for patients hospitalized with severe chronic obstructive pulmonary disease: resource intensity, hospitals costs, and survival. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.
Am J Med, 105 (1998), pp. 366-372
[11]
E Regidor, JL Gutiérrez-Fisac, ME Calle, AA Otero.
Patrón de mortalidad en España, 1998.
Med Clin (Barc), 118 (2002), pp. 13-15
[12]
M Bartolomé, J Almirall, J Morera, G Pera, V Ortún, J Bassa, et al.
A population-based study of the costs of care for community-acquired pneumonia.
Eur Respir J, 23 (2004), pp. 610-616
[13]
R Fernández Álvarez, JA Gullón Blanco, G Rubinos Cuadrado, A Jiménez Sosa, C Hernández García, A Medina Gonzálvez, et al.
Neumonía adquirida en la comunidad: influencia de la duración de la antibioterapia intravenosa en la estancia hospitalaria y relación coste/efectividad.
Arch Bronconeumol, 37 (2001), pp. 366-370
[14]
J González Moraleja, P Sesma, C González, ME López, JF García, JL Álvarez-Sala.
¿Cuál es el coste de las neumonías que ingresamos inadecuadamente?.
Arch Bronconeumol, 35 (1999), pp. 312-316
[15]
JM Bayas, A Vilella, M San Martín, A González, A Conesa, MA Asenjo.
Impacto sanitario de los ingresos por neumonía en un hospital de tercer nivel.
Med Clin (Barc), 116 (2001), pp. 694-695
[16]
J Whittle, CJ Lin, JR Lave, MJ Fine, KM Delaney, DZ Joyce, et al.
Relationship of provider characteristics to outcomes, process, and costs of care for community-acquired pneumonia.
Med Care, 36 (1998), pp. 977-987
[17]
A Capelastegui, PP España, JM Quintana, I Gorordo, A Martínez Urquiri, I Idoiaga, et al.
Pacientes ingresados por neumonía adquirida en la comunidad: estudio comparativo en función del servicio médico responsable.
Arch Bronconeumol, 41 (2005), pp. 300-306
[18]
RB Brown, P Iannini, P Gross, M Kunkel.
Impact of initial antibiotic choice on clinical outcomes in community-acquired pneumonia: analysis of a hospital claims-made database.
Chest, 123 (2003), pp. 1503-1511
[19]
PP Gleason, TP Meehan, JM Fine, DH Galusha, MJ Fine.
Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.
Arch Intern Med, 159 (1999), pp. 2562-2572
[20]
PM Houck, RF MacLehose, MS Niederman, JK Lowery.
Empiric antibiotic therapy and mortality among medicare pneumonia inpatients in 10 Western states: 1993, 1995, and 1997.
Chest, 119 (2001), pp. 1420-1426
[21]
GW Waterer, GW Somes, RG Wunderink.
Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.
Arch Intern Med, 161 (2001), pp. 1837-1842
[22]
MA Mufson, RJ Stanek.
Bacteremic pneumococcal pneumonia in one American city: a 20-year longitudinal study, 1978-1997.
Am J Med, 107 (1999), pp. 34S-43S
[23]
JA Martínez, JP Horcajada, M Almela, F Marco, A Soriano, E García, et al.
Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.
Clin Infect Dis, 36 (2003), pp. 389-395
[24]
DS Burgess, JS Lewis II.
Effect of macrolides as part of initial empiric therapy on medical outcomes for hospitalized patients with community-acquired pneumonia.
Clin Ther, 22 (2000), pp. 872-878
[25]
Aspa J, Rajas O, Rodríguez de Castro F, Huertas MC, Borderías L, Cabello FJ, et al. Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J. in revision 2005.
[26]
HK Johansen, TG Jensen, RB Dessau, B Lundgren, N Frimodt-Moller.
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo.
J Antimicrob Chemother, 46 (2000), pp. 973-980
[27]
LM Baddour, VL Yu, KP Klugman, C Feldman, A Ortqvist, J Rello, et al.
Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia.
Am J Respir Crit Care Med, 170 (2004), pp. 440-444
[28]
EA Halm, GE Switzer, BS Mittman, MB Walsh, CC Chang, MJ Fine.
What factors influence physicians' decisions to switch from intravenous to oral antibiotics for community-acquired pneumonia?.
J Gen Intern Med, 16 (2001), pp. 599-605
[29]
Menéndez R, Torres A, Zalacaín R, Aspa J, Martín-Villasclaras JJ, Borederías L, et al. Guidelines for the treatment of community-acquired pneumonia: an audit of adherence and outcome. Am J Respir Crit Care Med. in revision 2005.
Copyright © 2005. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)
